[1]
Baldini, S., Rigacci, L., Carrai, V., Alterini, R., Fjerza, R. and Bosi, A. 2012. PATIENTS WITH ≥ 20 X 109/L PLATELETS AT BASELINE MAY HAVE A PROMPT RESPONSE TO ROMIPLOSTIM DURING THE EARLY PHASE OF TREATMENT: AN ITALIAN SINGLE-INSTITUTION EXPERIENCE. Mediterranean Journal of Hematology and Infectious Diseases. 4, 1 (Jun. 2012), e2012044. DOI:https://doi.org/10.4084/mjhid.2012.044.